|
MRPL39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.355400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.430430E-02 |
| Normal-vs-Stage2 |
7.539500E-02 |
| Normal-vs-Stage3 |
6.394400E-02 |
| Normal-vs-Stage4 |
3.476800E-01 |
| Stage1-vs-Stage2 |
8.815200E-01 |
| Stage1-vs-Stage3 |
6.797600E-01 |
| Stage1-vs-Stage4 |
9.872800E-01 |
| Stage2-vs-Stage3 |
8.372800E-01 |
| Stage2-vs-Stage4 |
9.207200E-01 |
| Stage3-vs-Stage4 |
8.122000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.90920000000738E-05 |
| Normal-vs-AfricanAmerican |
4.472400E-01 |
| Normal-vs-Asian |
7.965600E-01 |
| Caucasian-vs-AfricanAmerican |
2.119700E-02 |
| Caucasian-vs-Asian |
1.288040E-01 |
| AfricanAmerican-vs-Asian |
5.360800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.387800E-04 |
| Normal-vs-Female |
4.471700E-02 |
| Male-vs-Female |
4.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.620200E-03 |
| Normal-vs-Extreme_Weight |
1.262140E-03 |
| Normal-vs-Obese |
1.107640E-01 |
| Normal-vs-Extreme_Obese |
6.398400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.798200E-01 |
| Normal_Weight-vs-Obese |
4.819600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.367200E-01 |
| Extreme_Weight-vs-Obese |
3.658000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.974600E-01 |
| Obese-vs-Extreme_Obese |
9.314400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.104400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.397700E-03 |
| Normal-vs-Age(61-80Yrs) |
9.777000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.917400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.754800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.192800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.692220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.299400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.613850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.008800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.991400E-04 |
| Normal-VS-Type2 PRCC |
4.634000E-02 |
| Normal-VS-KIRP CIMP |
7.102600E-01 |
| Normal-VS-Unclassified PRCC |
9.173400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.273800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.800800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.332960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.691600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.100200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.197400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.172100E-02 |
| Normal-vs-N1 |
1.440840E-01 |
| Normal-vs-N2 |
2.15910000000985E-06 |
| N0-vs-N1 |
7.379200E-01 |
| N0-vs-N2 |
9.268400E-02 |
| N1-vs-N2 |
4.978400E-02 |
|
|
